In Vivo Studies of [161Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2–Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth Suppression.
Saved in:
| Title: | In Vivo Studies of [161Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2–Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth Suppression. |
|---|---|
| Authors: | Cold, Sigrid1,2,3 (AUTHOR), Sadasivam, Pragalath1 (AUTHOR), Wessel, Mette M.1 (AUTHOR), Ischyropoulou, Myrto1 (AUTHOR), Fonslet, Jesper1 (AUTHOR), Engel, Trine B.1 (AUTHOR), Nielsen, Carsten H.1 (AUTHOR), Kjaer, Andreas2,3 (AUTHOR), Kristensen, Lotte K.1 (AUTHOR) lkk@minervaimaging.com |
| Source: | Journal of Nuclear Medicine. Apr2026, Vol. 67 Issue 4, p542-547. 6p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01615505 |
|---|---|
| DOI: | 10.2967/jnumed.125.269741 |
